Bio-Thera and Dr. Reddy's partner for biosimilar commercialization in Southeast Asia, expanding access to affordable ...

Psoriasis is a chronic skin disorder characterized ... The same issue might apply to golimumab (Simponi; Centocor Ortho Biotech), which has recently been approved for rheumatoid arthritis ...

Two additional TNF blockers recently approved for the treatment of rheumatoid arthritis, golimumab and certolizumab pegol, also seem to hold promise for treating psoriasis. The Active Comparator ...

With this partnership, they aim to enhance access to affordable treatments for patients suffering from autoimmune diseases ...